The voyage of stem cell toward terminal differentiation: A brief overview

Acta Biochimica et Biophysica Sinica

Volumn 44, Issue 6, 2012, Pages 463-475

  Bhattacharyya, Shalmoli ^a   Kumar, Ajay ^a   Lal Khanduja, Kishan ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

cell fate; differentiation; regulation; signaling; stem cells

Indexed keywords

BONE MORPHOGENETIC PROTEIN; PROTEIN TYROSINE KINASE; SIGNAL PEPTIDE;

CELL DIFFERENTIATION; EMBRYONIC STEM CELL; GERM CELL; HEMATOPOIETIC STEM CELL; HUMAN; MULTIPOTENT STEM CELL; PHYSIOLOGY; REGENERATIVE MEDICINE; REVIEW; SIGNAL TRANSDUCTION; STEM CELL; STEM CELL NICHE;

BONE MORPHOGENETIC PROTEINS; CELL DIFFERENTIATION; EMBRYONIC STEM CELLS; GERM CELLS; HEMATOPOIETIC STEM CELLS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MULTIPOTENT STEM CELLS; RECEPTOR PROTEIN-TYROSINE KINASES; REGENERATIVE MEDICINE; SIGNAL TRANSDUCTION; STEM CELL NICHE; STEM CELLS;

HARNESS;

EID: 84861859088     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gms027     Document Type: Review

References (166)

1. Wells JM and Melton DA. Vertebrate endoderm development. Annu Rev Cell Dev Biol 1999, 15:393-410.
2. Li L and Clevers H. Coexistence of quiescent and active adult stem cells in mammals. Science 2010, 327:542-545.
3. Petersen BE, Bowen WC, Patrene KD, Mars WM, Sullivan AK, Murase N and Boggs SS, et al. Bone marrow as a potential source of hepatic oval cells. Science 1999, 284:1168-1170.
4. Blau HM. A twist of fate. Nature 2002, 419:437.
5. Takahashi K and Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
6. Horton RE, Millman JR, Colton CK and Auguste DT. Engineering microenvironments for embryonic stem cell differentiation to cardiomyocytes. Regen Med 2009, 4:721-732.
7. Warr MR, Pietras EM and Passegue E. Mechanisms controlling hematopoietic stem cell functions during normal hematopoiesis and hematological malignancies. Wiley Interdiscip Rev Syst Biol Med 2011, 3:681-701.
8. Iglesias-Bartolome R G J. Signaling circuitries controlling stem cell fate: to be or not to be. Curr Opin Cell Biol 2011, 23:716-723.
9. Saxena AK, Singh D and Gupta J. Role of stem cell research in therapeutic purpose-a hope for new horizon in medical biotechnology. J Exp Ther Oncol 2010, 8:223-233.
10. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS and Jones JM. Embryonic stem cell lines derived from human blastocysts. Science 1998, 282:1145-1147.
11. Wylie C. Germ cells. Cell 1999, 96:165-174.
12. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD and Moorman MA, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
13. Jaiswal RK, Jaiswal N, Bruder SP, Mbalaviele G, Marshak DR and Pittenger MF. Adult human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated protein kinase. J Biol Chem 2000, 275:9645-9652.
14. Ramalho-Santos M, Yoon S, Matsuzaki Y, Mulligan RC and Melton DA. "Stemness": transcriptional profiling of embryonic and adult stem cells. Science 2002, 298:597-600.
15. Wakao S, Kitada M, Kuroda Y, Shigemoto T, Matsuse D, Akashi H and Tanimura Y, et al. Multilineage-differentiating stress-enduring (Muse) cells are a primary source of induced pluripotent stem cells in human fibroblasts. Proc Natl Acad Sci USA 2011, 108:9875-9880.
16. Lagasse E, Connors H, Al-Dhalimy M, Reitsma M, Dohse M, Osborne L and Wang X, et al. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med 2000, 6:1229-1234.
17. Wlodarski K and Wlodarski P. Regulation of the differentiation of bone marrow mesenchymal stem cells into osteoblastic and adipogenic lineage. Chir Narzadow Ruchu Ortop Pol 2011, 76:96-98.
18. Li L and Neaves WB. Normal stem cells and cancer stem cells: the niche matters. Cancer Res 2006, 66:4553-4557.
19. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B and Pickel J, et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001, 410:701-705.
20. Yamashita YM, Yuan H, Cheng J and Hunt AJ. Polarity in stem cell division: asymmetric stem cell division in tissue homeostasis. Cold Spring Harb Perspect Biol 2010, 2:a001313.
21. Arai F and Suda T. Maintenance of quiescent hematopoietic stem cells in the osteoblastic niche. Ann N Y Acad Sci 2007, 1106:41-53.
22. Niwa H, Miyazaki J and Smith AG. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 2000, 24:372-376.
23. Wilson A, Murphy MJ, Oskarsson T, Kaloulis K, Bettess MD, Oser GM and Pasche AC, et al. c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation. Genes Dev 2004, 18:2747-2763.
24. Arnold K, Sarkar A, Yram MA, Polo JM, Bronson R, Sengupta S and Seandel M, et al. Sox2 (+) adult stem and progenitor cells are important for tissue regeneration and survival of mice. Cell Stem Cell 2011, 9:317-329.
25. Chen X, Wu R, Feng S, Gu B, Dai L, Zhang M and Zhao X. Single cell derived murine embryonic stem cell clones stably express Rex1-specific green fluorescent protein and their differentiation study. Biochem Biophys Res Commun 2007, 362:467-473.
26. Wang J, Levasseur DN and Orkin SH. Requirement of Nanog dimerization for stem cell self-renewal and pluripotency. Proc Natl Acad Sci USA 2008, 105:6326-6331.
27. Kim MO, Kim SH, Cho YY, Nadas J, Jeong CH, Yao K and Kim DJ, et al. ERK1 and ERK2 regulate embryonic stem cell self-renewal through phosphorylation of Klf4. Nat Struct Mol Biol 2012, 19:283-290.
28. Metcalf D. The unsolved enigmas of leukemia inhibitory factor. Stem Cells 2003, 21:5-14.
29. Tsutsumi S, Shimazu A, Miyazaki K, Pan H, Koike C, Yoshida E and Takagishi K, et al. Retention of multilineage differentiation potential of mesenchymal cells during proliferation in response to FGF. Biochem Biophys Res Commun 2001, 288:413-419.
30. Kleber M and Sommer L. Wnt signaling and the regulation of stem cell function. Curr Opin Cell Biol 2004, 16:681-687.
31. Jiang Y, Vaessen B, Lenvik T, Blackstad M, Reyes M and Verfaillie CM. Multipotent progenitor cells can be isolated from postnatal murine bone marrow, muscle, and brain. Exp Hematol 2002, 30:896-904.
32. Schaniel C, Sirabella D, Qiu J, Niu X, Lemischka IR and Moore KA. Wnt-inhibitory factor 1 dysregulation of the bone marrow niche exhausts hematopoietic stem cells. Blood 2011, 118:2420-2429.
33. Kalani MY, Cheshier SH, Cord BJ, Bababeygy SR, Vogel H, Weissman IL and Palmer TD, et al. Wnt-mediated self-renewal of neural stem/progenitor cells. Proc Natl Acad Sci USA 2008, 105:16970-16975.
34. Yeung TM, Chia LA, Kosinski CM and Kuo CJ. Regulation of self-renewal and differentiation by the intestinal stem cell niche. Cell Mol Life Sci 2011, 68:2513-2523.
35. Masuya M, Drake CJ, Fleming PA, Reilly CM, Zeng H, Hill WD and Martin-Studdard A, et al. Hematopoietic origin of glomerular mesangial cells. Blood 2003, 101:2215-2218.
36. Vassilopoulos G, Wang PR and Russell DW. Transplanted bone marrow regenerates liver by cell fusion. Nature 2003, 422:901-904.
37. Floisand Y and Sioud M. Recent advances in hematopoietic stem cell transplantation and perspectives of RNAi applications. Methods Mol Biol 2010, 629:507-523.
38. Vieira HL, Alves PM and Vercelli A. Modulation of neuronal stem cell differentiation by hypoxia and reactive oxygen species. Prog Neurobiol 2011, 93:444-455.
39. He X, Marchionni L, Hansel DE, Yu W, Sood A, Yang J and Parmigiani G, et al. Differentiation of a highly tumorigenic basal cell compartment in urothelial carcinoma. Stem Cells 2009, 27:1487-1495.
40. Salehi M, Pasbakhsh P, Soleimani M, Abbasi M, Hasanzadeh G, Modaresi MH and Sobhani A. Repair of spinal cord injury by co-transplantation of embryonic stem cell-derived motor neuron and olfactory ensheathing cell. Iran Biomed J 2009, 13:125-135.
41. Singh UP, Singh NP, Singh B, Mishra MK, Nagarkatti M, Nagarkatti PS and Singh SR. Stem cells as potential therapeutic targets for inflammatory bowel disease. Front Biosci (Schol Ed) 2010, 2:993-1008.
42. Lunn JS, Sakowski SA, Hur J and Feldman EL. Stem cell technology for neurodegenerative diseases. Ann Neurol 2011, 70:353-361.
43. Glaser DE, Gower RM, Lauer NE, Tam K, Blancas AA, Shih AJ and Simon SI, et al. Functional characterization of embryonic stem cellderived endothelial cells. J Vasc Res 2011, 48:415-428.
44. Tamura K, Ohgo S and Yokoyama H. Limb blastema cell: a stem cell for morphological regeneration. Dev Growth Differ 2010, 52:89-99.
45. Hendry C, Rumballe B, Moritz K and Little MH. Defining and redefining the nephron progenitor population. Pediatr Nephrol 2011, 26:1395-1406.
46. Otto WR and Wright NA. Mesenchymal stem cells: from experiment to clinic. Fibrogenesis Tissue Repair 2011, 4:20.
47. LoCascio SA, Spinelli J and Kurtz J. Hematopoietic stem cell transplantation for the treatment of autoimmunity in type 1 diabetes. Curr Stem Cell Res Ther 2011, 6:29-37.
48. Singh MS and MacLaren RE. Stem cells as a therapeutic tool for the blind: biology and future prospects. Proc Biol Sci 2011, 278:3009-3016.
49. Huisman MA and Rivolta MN. Neural crest stem cells and their potential application in a therapy for deafness. Front Biosci (Schol Ed) 2012, 4:121-132.
50. Watanabe J, Kondo H and Hatake K. Autologous stem cell transplantations for recurrent adult T cell leukaemia/lymphoma using highly purified CD34+ cells derived from cryopreserved peripheral blood stem cells. Leuk Lymphoma 2001, 42:1115-1117.
51. Werbowetski-Ogilvie TE, Coudiere Morrison L, Fiebig-Comyn A and Bhatia M. In vivo generation of neural tumors from neoplastic pluripotent stem cells models early human pediatric brain tumor formation. Stem Cells 2012, 30:392-404.
52. Guo L, Abrams RM, Babiarz JE, Cohen JD, Kameoka S, Sanders MJ and Chiao E, et al. Estimating the risk of drug-induced proarrhythmia using human induced pluripotent stem cell-derived cardiomyocytes. Toxicol Sci 2011, 123:281-289.
53. Jiang X and Lu S. Research advances in induced pluripotent stem cells. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2011, 33:456-461.
54. Chagastelles PC, Nardi NB and Camassola M. Biology and applications of mesenchymal stem cells. Sci Prog 2010, 93:113-127.
55. Pera MF and Tam PP. Extrinsic regulation of pluripotent stem cells. Nature 2010, 465:713-720.
56. Keller G. Embryonic stem cell differentiation: emergence of a new era in biology and medicine. Genes Dev 2005, 19:1129-1155.
57. Nakano T, Kodama H and Honjo T. Generation of lymphohematopoietic cells from embryonic stem cells in culture. Science 1994, 265:1098-1101.
58. Tada S, Era T, Furusawa C, Sakurai H, Nishikawa S, Kinoshita M and Nakao K, et al. Characterization of mesendoderm: a diverging point of the definitive endoderm and mesoderm in embryonic stem cell differentiation culture. Development 2005, 132:4363-4374.
59. Rohwedel J, Maltsev V, Bober E, Arnold HH, Hescheler J and Wobus AM. Muscle cell differentiation of embryonic stem cells reflects myogenesis in vivo: developmentally regulated expression of myogenic determination genes and functional expression of ionic currents. Dev Biol 1994, 164:87-101.
60. Hollnagel A, Oehlmann V, Heymer J, Ruther U and Nordheim A. Id genes are direct targets of bone morphogenetic protein induction in embryonic stem cells. J Biol Chem 1999, 274:19838-19845.
61. Wiles MV and Johansson BM. Embryonic stem cell development in a chemically defined medium. Exp Cell Res 1999, 247:241-248.
62. Rubin JS, Chan AM, Bottaro DP, Burgess WH, Taylor WG, Cech AC and Hirschfield DW, et al. A broad-spectrum human lung fibroblastderived mitogen is a variant of hepatocyte growth factor. Proc Natl Acad Sci USA 1991, 88:415-419.
63. Glaser T and Brustle O. Retinoic acid induction of ES-cell-derived neurons: the radial glia connection. Trends Neurosci 2005, 28:397-400.
64. Klingseisen A, Clark IB, Gryzik T and Muller HA. Differential and overlapping functions of two closely related Drosophila FGF8-like growth factors in mesoderm development. Development 2009, 136:2393-2402.
65. Wobus AM, Grosse R and Schoneich J. Specific effects of nerve growth factor on the differentiation pattern of mouse embryonic stem cells in vitro. Biomed Biochim Acta 1988, 47:965-973.
66. Wiles MV and Keller G. Multiple hematopoietic lineages develop from embryonic stem (ES) cells in culture. Development 1991, 111:259-267.
67. Biesecker LG and Emerson SG. Interleukin-6 is a component of human umbilical cord serum and stimulates hematopoiesis in embryonic stem cells in vitro. Exp Hematol 1993, 21:774-778.
68. Young JE, Martinez RA and La Spada AR. Nutrient deprivation induces neuronal autophagy and implicates reduced insulin signaling in neuroprotective autophagy activation. J Biol Chem 2009, 284:2363-2373.
69. Slager HG, Van Inzen W, Freund E, Van den Eijnden-Van Raaij AJ and Mummery CL. Transforming growth factor-beta in the early mouse embryo: implications for the regulation of muscle formation and implantation. Dev Genet 1993, 14:212-224.
70. Allan EH, Ho PW, Umezawa A, Hata J, Makishima F, Gillespie MT and Martin TJ. Differentiation potential of a mouse bone marrow stromal cell line. J Cell Biochem 2003, 90:158-169.
71. Fink T, Abildtrup L, Fogd K, Abdallah BM, Kassem M, Ebbesen P and Zachar V. Induction of adipocyte-like phenotype in human mesenchymal stem cells by hypoxia. Stem Cells 2004, 22:1346-1355.
72. de Crombrugghe B, Lefebvre V, Behringer RR, Bi W, Murakami S and Huang W. Transcriptional mechanisms of chondrocyte differentiation. Matrix Biol 2000, 19:389-394.
73. Chiou M, Xu Y and Longaker MT. Mitogenic and chondrogenic effects of fibroblast growth factor-2 in adipose-derived mesenchymal cells. Biochem Biophys Res Commun 2006, 343:644-652.
74. Estes BT, Wu AW and Guilak F. Potent induction of chondrocytic differentiation of human adipose-derived adult stem cells by bone morphogenetic protein 6. Arthritis Rheum 2006, 54:1222-1232.
75. Haider M, Cappello J, Ghandehari H and Leong KW. In vitro chondrogenesis of mesenchymal stem cells in recombinant silk-elastinlike hydrogels. Pharm Res 2008, 25:692-699.
76. Deans RJ and Moseley AB. Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol 2000, 28:875-884.
77. Celil AB and Campbell PG. BMP-2 and insulin-like growth factor-I mediate Osterix (Osx) expression in human mesenchymal stem cells via the MAPK and protein kinase D signaling pathways. J Biol Chem 2005, 280:31353-31359.
78. Aggarwal S and Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005, 105:1815-1822.
79. Ducy P, Zhang R, Geoffroy V, Ridall AL and Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 1997, 89:747-754.
80. Hong JH, Hwang ES, McManus MT, Amsterdam A, Tian Y, Kalmukova R and Mueller E, et al. TAZ, a transcriptional modulator of mesenchymal stem cell differentiation. Science 2005, 309:1074-1078.
81. Hoffmann HM, Catron KM, van Wijnen AJ, McCabe LR, Lian JB, Stein GS and Stein JL. Transcriptional control of the tissue-specific, developmentally regulated osteocalcin gene requires a binding motif for the Msx family of homeodomain proteins. Proc Natl Acad Sci USA 1994, 91:12887-12891.
82. Kim DH, Yoo KH, Choi KS, Choi J, Choi SY, Yang SE and Yang YS, et al. Gene expression profile of cytokine and growth factor during differentiation of bone marrow-derived mesenchymal stem cell. Cytokine 2005, 31:119-126.
83. Rafii S, Meeus S, Dias S, Hattori K, Heissig B, Shmelkov S and Rafii D, et al. Contribution of marrow-derived progenitors to vascular and cardiac regeneration. Semin Cell Dev Biol 2002, 13:61-67.
84. Conway DS, Pearce LA, Chin BS, Hart RG and Lip GY. Plasma von Willebrand factor and soluble p-selectin as indices of endothelial damage and platelet activation in 1321 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors. Circulation 2002, 106:1962-1967.
85. Stockinger A, Eger A, Wolf J, Beug H and Foisner R. E-cadherin regulates cell growth by modulating proliferation-dependent beta-catenin transcriptional activity. J Cell Biol 2001, 154:1185-1196.
86. Behfar A, Zingman LV, Hodgson DM, Rauzier JM, Kane GC, Terzic A and Puceat M. Stem cell differentiation requires a paracrine pathway in the heart. FASEB J 2002, 16:1558-1566.
87. Sachinidis A, Fleischmann BK, Kolossov E, Wartenberg M, Sauer H and Hescheler J. Cardiac specific differentiation of mouse embryonic stem cells. Cardiovasc Res 2003, 58:278-291.
88. Paquin J, Danalache BA, Jankowski M, McCann SM and Gutkowska J. Oxytocin induces differentiation of P19 embryonic stem cells to cardiomyocytes. Proc Natl Acad Sci USA 2002, 99:9550-9555.
89. Wu H, Lee SH, Gao J, Liu X and Iruela-Arispe ML. Inactivation of erythropoietin leads to defects in cardiac morphogenesis. Development 1999, 126:3597-3605.
90. Xu C, Police S, Rao N and Carpenter MK. Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Circ Res 2002, 91:501-508.
91. Takahashi T, Lord B, Schulze PC, Fryer RM, Sarang SS, Gullans SR and Lee RT. Ascorbic acid enhances differentiation of embryonic stem cells into cardiac myocytes. Circulation 2003, 107:1912-1916.
92. Wobus AM, Kaomei G, Shan J, Wellner MC, Rohwedel J, Ji G and Fleischmann B, et al. Retinoic acid accelerates embryonic stem cellderived cardiac differentiation and enhances development of ventricular cardiomyocytes. J Mol Cell Cardiol 1997, 29:1525-1539.
93. Zandstra PW, Bauwens C, Yin T, Liu Q, Schiller H, Zweigerdt R and Pasumarthi KB, et al. Scalable production of embryonic stem cell-derived cardiomyocytes. Tissue Eng 2003, 9:767-778.
94. Ventura C and Maioli M. Opioid peptide gene expression primes cardiogenesis in embryonal pluripotent stem cells. Circ Res 2000, 87:189-194.
95. McBurney MW, Jones-Villeneuve EM, Edwards MK and Anderson PJ. Control of muscle and neuronal differentiation in a cultured embryonal carcinoma cell line. Nature 1982, 299:165-167.
96. Skerjanc IS, Petropoulos H, Ridgeway AG and Wilton S. Myocyte enhancer factor 2C and Nkx2-5 up-regulate each other's expression and initiate cardiomyogenesis in P19 cells. J Biol Chem 1998, 273:34904-34910.
97. Sato Y, Araki H, Kato J, Nakamura K, Kawano Y, Kobune M and Sato T, et al. Human mesenchymal stem cells xenografted directly to rat liver are differentiated into human hepatocytes without fusion. Blood 2005, 106:756-763.
98. Masson NM, Currie IS, Terrace JD, Garden OJ, Parks RW and Ross JA. Hepatic progenitor cells in human fetal liver express the oval cell marker Thy-1. Am J Physiol Gastrointest Liver Physiol 2006, 291:G45-G54.
99. Katoh M. WNT signaling in stem cell biology and regenerative medicine. Curr Drug Targets 2008, 9:565-570.
100. Schenke-Layland K, Nsair A, Van Handel B, Angelis E, Gluck JM, Votteler M and Goldhaber JI, et al. Recapitulation of the embryonic cardiovascular progenitor cell niche. Biomaterials 2011, 32:2748-2756.
101. Komori T. Regulation of bone development and extracellular matrix protein genes by RUNX2. Cell Tissue Res 2010, 339:189-195.
102. Quintana L, zur Nieden NI and Semino CE. Morphogenetic and regulatory mechanisms during developmental chondrogenesis: new paradigms for cartilage tissue engineering. Tissue Eng Part B Rev 2009, 15:29-41.
103. Cheng A and Genever PG. SOX9 determines RUNX2 transactivity by directing intracellular degradation. J Bone Miner Res 2011, 25:2680-2689.
104. Shin MK, Jang YH, Yoo HJ, Kang DW, Park MH, Kim MK and Seo DS, et al. fMLP promotes osteoblast differentiation via the N-formyl peptide receptor 1-mediated signaling pathway in human mesenchymal stem cells from bone marrow. J Biol Chem 2011, 286:17133-17143.
105. Lizcano F, Romero C and Vargas D. Regulation of adipogenesis by nuclear receptor PPARgamma is modulated by the histone demethylase JMJD2C. Genet Mol Biol 2011, 34:19-24.
106. Perera TD, Dwork AJ, Keegan KA, Thirumangalakudi L, Lipira CM, Joyce N and Lange C, et al. Necessity of hippocampal neurogenesis for the therapeutic action of antidepressants in adult nonhuman primates. PLoS One 2011, 6:e17600.
107. Duckmanton A, Kumar A, Chang YT and Brockes JP. A single-cell analysis of myogenic dedifferentiation induced by small molecules. Chem Biol 2005, 12:1117-1126.
108. Lyssiotis CA, Lairson LL, Boitano AE, Wurdak H, Zhu S and Schultz PG. Chemical control of stem cell fate and developmental potential. Angew Chem Int Ed Engl 2011, 50:200-242.
109. Hao J, Daleo MA, Murphy CK, Yu PB, Ho JN, Hu J and Peterson RT, et al. Dorsomorphin, a selective small molecule inhibitor of BMP signaling, promotes cardiomyogenesis in embryonic stem cells. PLoS One 2008, 3:e2904.
110. Gould A and Missailidis S. Targeting the hedgehog pathway: the development of cyclopamine and the development of anti-cancer drugs targeting the hedgehog pathway. Mini Rev Med Chem 2011, 11:200-213.
111. Wang H, Hao J and Hong CC. Cardiac induction of embryonic stem cells by a small molecule inhibitor of Wnt/beta-catenin signaling. ACS Chem Biol 2011, 6:192-197.
112. Engler AJ, Sen S, Sweeney HL and Discher DE. Matrix elasticity directs stem cell lineage specification. Cell 2006, 126:677-689.
113. Sundelacruz S, Levin M and Kaplan DL. Membrane potential controls adipogenic and osteogenic differentiation of mesenchymal stem cells. PLoS One 2008, 3:e3737.
114. Kilian KA, Bugarija B, Lahn BT and Mrksich M. Geometric cues for directing the differentiation of mesenchymal stem cells. Proc Natl Acad Sci USA 2010, 107:4872-4877.
115. Nusse R and Varmus HE. Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell 1982, 31:99-109.
116. Wodarz A and Nusse R. Mechanisms of Wnt signaling in development. Annu Rev Cell Dev Biol 1998, 14:59-88.
117. Tamai K, Semenov M, Kato Y, Spokony R, Liu C, Katsuyama Y and Hess F, et al. LDL-receptor-related proteins in Wnt signal transduction. Nature 2000, 407:530-535.
118. Willert K and Nusse R. Beta-catenin: a key mediator of Wnt signaling. Curr Opin Genet Dev 1998, 8:95-102.
119. Cavallo RA, Cox RT, Moline MM, Roose J, Polevoy GA, Clevers H and Peifer M, et al. Drosophila Tcf and Groucho interact to repress Wingless signalling activity. Nature 1998, 395:604-608.
120. Eastman Q and Grosschedl R. Regulation of LEF-1/TCF transcription factors by Wnt and other signals. Curr Opin Cell Biol 1999, 11:233-240.
121. Austin TW, Solar GP, Ziegler FC, Liem L and Matthews W. A role for the Wnt gene family in hematopoiesis: expansion of multilineage progenitor cells. Blood 1997, 89:3624-3635.
122. Massague J. TGF-beta signal transduction. Annu Rev Biochem 1998, 67:753-791.
123. Ying QL and Smith AG. Defined conditions for neural commitment and differentiation. Methods Enzymol 2003, 365:327-341.
124. Chen D, Ji X, Harris MA, Feng JQ, Karsenty G, Celeste AJ and Rosen V, et al. Differential roles for bone morphogenetic protein (BMP) receptor type IB and IA in differentiation and specification of mesenchymal precursor cells to osteoblast and adipocyte lineages. J Cell Biol 1998, 142:295-305.
125. He XC, Zhang J, Tong WG, Tawfik O, Ross J, Scoville DH and Tian Q, et al. BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt-beta-catenin signaling. Nat Genet 2004, 36:1117-1121.
126. Derynck R and Zhang YE. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 2003, 425:577-584.
127. Leatherbarrow JR and Halfon MS. Identification of receptor- tyrosinekinase-signaling target genes reveals receptor-specific activities and pathway branchpoints during Drosophila development. Genetics 2009, 181:1335-1345.
128. Anneren C. Tyrosine kinase signalling in embryonic stem cells. Clin Sci (Lond) 2008, 115:43-55.
129. Reubinoff BE, Itsykson P, Turetsky T, Pera MF, Reinhartz E, Itzik A and Ben-Hur T. Neural progenitors from human embryonic stem cells. Nat Biotechnol 2001, 19:1134-1140.
130. Jackson RA, Nurcombe V and Cool SM. Coordinated fibroblast growth factor and heparan sulfate regulation of osteogenesis. Gene 2006, 379:79-91.
131. Kulterer B, Friedl G, Jandrositz A, Sanchez-Cabo F, Prokesch A, Paar C and Scheideler M, et al. Gene expression profiling of human mesenchymal stem cells derived from bone marrow during expansion and osteoblast differentiation. BMC Genomics 2007, 8:70.
132. Vallier L, Alexander M and Pedersen RA. Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells. J Cell Sci 2005, 118:4495-4509.
133. Heilig C, Brosius F, Siu B, Concepcion L, Mortensen R, Heilig K and Zhu M, et al. Implications of glucose transporter protein type 1 (GLUT1)-haplodeficiency in embryonic stem cells for their survival in response to hypoxic stress. Am J Pathol 2003, 163:1873-1885.
134. Saldeen J, Kriz V, Agren N and Welsh M. SHB and angiogenic factors promote ES cell differentiation to insulin-producing cells. Biochem Biophys Res Commun 2006, 344:517-524.
135. Sachinidis A, Kolossov E, Fleischmann BK and Hescheler J. Generation of cardiomyocytes from embryonic stem cells experimental studies. Herz 2002, 27:589-597.
136. Ng F, Boucher S, Koh S, Sastry KS, Chase L, Lakshmipathy U and Choong C, et al. PDGF, TGF-beta, and FGF signaling is important for differentiation and growth of mesenchymal stem cells (MSCs): transcriptional profiling can identify markers and signaling pathways important in differentiation of MSCs into adipogenic, chondrogenic, and osteogenic lineages. Blood 2008, 112:295-307.
137. Burdon T, Chambers I, Stracey C, Niwa H and Smith A. Signaling mechanisms regulating self-renewal and differentiation of pluripotent embryonic stem cells. Cells Tissues Organs 1999, 165:131-143.
138. Schaper F, Gendo C, Eck M, Schmitz J, Grimm C, Anhuf D and Kerr IM, et al. Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression. Biochem J 1998, 335(Pt 3):557-565.
139. Hibi M and Hirano T. Gab-family adapter molecules in signal transduction of cytokine and growth factor receptors, and T and B cell antigen receptors. Leuk Lymphoma 2000, 37:299-307.
140. Burdon T, Stracey C, Chambers I, Nichols J and Smith A. Suppression of SHP-2 and ERK signalling promotes self-renewal of mouse embryonic stem cells. Dev Biol 1999, 210:30-43.
141. Artavanis-Tsakonas S, Rand MD and Lake RJ. Notch signaling: cell fate control and signal integration in development. Science 1999, 284:770-776.
142. Qi H, Rand MD, Wu X, Sestan N, Wang W, Rakic P and Xu T, et al. Processing of the notch ligand delta by the metalloprotease Kuzbanian. Science 1999, 283:91-94.
143. Kadesch T. Notch signaling: a dance of proteins changing partners. Exp Cell Res 2000, 260:1-8.
144. Milner LA and Bigas A. Notch as a mediator of cell fate determination in hematopoiesis: evidence and speculation. Blood 1999, 93:2431-2448.
145. Huang JK and Franklin RJ. Regenerative medicine in multiple sclerosis: identifying pharmacological targets of adult neural stem cell differentiation. Neurochem Int 2011, 59:329-332.
146. Aguirre A, Rubio ME and Gallo V. Notch and EGFR pathway interaction regulates neural stem cell number and self-renewal. Nature 2010, 467:323-327.
147. Sibilia M, Wagner B, Hoebertz A, Elliott C, Marino S, Jochum W and Wagner EF. Mice humanised for the EGF receptor display hypomorphic phenotypes in skin, bone and heart. Development 2003, 130:4515-4525.
148. Tsukui T, Capdevila J, Tamura K, Ruiz-Lozano P, Rodriguez-Esteban C, Yonei-Tamura S and Magallon J, et al. Multiple left-right asymmetry defects in Shh (-/-) mutant mice unveil a convergence of the shh and retinoic acid pathways in the control of Lefty-1. Proc Natl Acad Sci USA 1999, 96:11376-11381.
149. Zhu G, Mehler MF, Zhao J, Yu Yung S and Kessler JA. Sonic hedgehog and BMP2 exert opposing actions on proliferation and differentiation of embryonic neural progenitor cells. Dev Biol 1999, 215:118-129.
150. Bhardwaj G, Murdoch B, Wu D, Baker DP, Williams KP, Chadwick K and Ling LE, et al. Sonic hedgehog induces the proliferation of primitive human hematopoietic cells via BMP regulation. Nat Immunol 2001, 2:172-180.
151. Liu S, Dontu G, Mantle ID, Patel S, Ahn NS, Jackson KW and Suri P, et al. Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res 2006, 66:6063-6071.
152. Ahn S and Joyner AL. In vivo analysis of quiescent adult neural stem cells responding to Sonic hedgehog. Nature 2005, 437:894-897.
153. Wang Y, Yates F, Naveiras O, Ernst P and Daley GQ. Embryonic stem cell-derived hematopoietic stem cells. Proc Natl Acad Sci USA 2005, 102:19081-19086.
154. Sauvageau G, Lansdorp PM, Eaves CJ, Hogge DE, Dragowska WH, Reid DS and Largman C, et al. Differential expression of homeobox genes in functionally distinct CD34+ subpopulations of human bone marrow cells. Proc Natl Acad Sci USA 1994, 91:12223-12227.
155. Thorsteinsdottir U, Sauvageau G and Humphries RK. Enhanced in vivo regenerative potential of HOXB4-transduced hematopoietic stem cells with regulation of their pool size. Blood 1999, 94:2605-2612.
156. Walker E, Manias JL, Chang WY and Stanford WL. PCL2 modulates gene regulatory networks controlling self-renewal and commitment in embryonic stem cells. Cell Cycle 2011, 10:45-51.
157. Rosner MH, Vigano MA, Ozato K, Timmons PM, Poirier F, Rigby PW and Staudt LM. A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo. Nature 1990, 345:686-692.
158. Okamoto K, Okazawa H, Okuda A, Sakai M, Muramatsu M and Hamada H. A novel octamer binding transcription factor is differentially expressed in mouse embryonic cells. Cell 1990, 60:461-472.
159. Marchand M, Horcajadas JA, Esteban FJ, McElroy SL, Fisher SJ and Giudice LC. Transcriptomic signature of trophoblast differentiation in a human embryonic stem cell model. Biol Reprod 2011, 84:1258-1271.
160. Tan BS, Lonic A, Morris MB, Rathjen PD and Rathjen J. The amino acid transporter Snat2 mediates L-proline induced differentiation of ES cells. Am J Physiol Cell Physiol 2011, 300:C1270-C1279.
161. Burnstock G and Ulrich H. Purinergic signaling in embryonic and stem cell development. Cell Mol Life Sci 2011, 68:1369-1394.
162. Ben-Shushan E, Sharir H, Pikarsky E and Bergman Y. A dynamic balance between ARP-1/COUP-TFII, EAR-3/COUP-TFI, and retinoic acid receptor: retinoid X receptor heterodimers regulates Oct-3/4 expression in embryonal carcinoma cells. Mol Cell Biol 1995, 15:1034-1048.
163. Meshorer E and Misteli T. Chromatin in pluripotent embryonic stem cells and differentiation. Nat Rev Mol Cell Biol 2006, 7:540-546.
164. Feldman N, Gerson A, Fang J, Li E, Zhang Y, Shinkai Y and Cedar H, et al. G9a-mediated irreversible epigenetic inactivation of Oct-3/4 during early embryogenesis. Nat Cell Biol 2006, 8:188-194.
165. Kim YJ, Cecchini KR and Kim TH. Conserved, developmentally regulated mechanism couples chromosomal looping and heterochromatin barrier activity at the homeobox gene A locus. Proc Natl Acad Sci USA 2011, 108:7391-7396.
166. Wang C, Tai Y, Lisanti MP and Liao DJ. c-Myc induction of programmed cell death may contribute to carcinogenesis: a perspective inspired by several concepts of chemical carcinogenesis. Cancer Biol Ther 2011, 11:615-626.